Description
BPC-157 + TB-500 Blend 20mg — Dual Healing-Pathway Research Stack
This BPC-157 + TB-500 peptide blend combines two of the most studied healing-research peptides into a single pre-combined vial. Peptalix Labs supplies this blend at a verified purity of 99.79%, tested via a full QC panel by ILS Laboratories (ISO/IEC 17025 accredited, San Diego). GMP-sourced, lyophilised. Fast USA same-day shipping with delivery to Canada, Australia, the UK and Europe.
Certificate of Analysis
This blend is independently tested by ILS Laboratories, an ISO/IEC 17025 accredited facility in San Diego, CA — a more comprehensive panel than standard purity testing. COA #COA-2026-RNX8QR (issued 06/08/2026) confirmed 99.79% purity, with BPC-157 at 10.70mg and TB-500/TB-4 at 10.29mg (Lot 128-01-SM). The panel includes a negative fentanyl screen and full heavy metals analysis (arsenic, cadmium, chromium, mercury, lead — all not detected). Independently verifiable at portal.ils-lab.com, Access Code 6LSDDDWA.
Research Background
This blend allows researchers to study BPC-157’s gastric/tissue healing and angiogenesis pathways alongside TB-500’s actin-regulation and cell-migration mechanisms within a single combined research formulation. For triple-compound research, see the Wolverine+ blend which adds KPV.
Product Specifications
- Product
- BPC-157 / TB-500 Blend 20mg
- Components
- BPC-157 10.70mg + TB-500/TB-4 10.29mg per vial
- Appearance
- Lyophilised, Good
- Purity
- 99.79% (Full QC Panel — HPLC)
- Net Peptide Content
- 20.99 mg total per vial
- Lot Number
- 128-01-SM
- COA Number
- COA-2026-RNX8QR
- Testing Lab
- ILS Laboratories, San Diego (ISO/IEC 17025 Accredited)
- Fentanyl Screen
- Not Detected (Pass)
- Heavy Metals
- Arsenic, Cadmium, Chromium, Mercury, Lead — All Not Detected (Pass)
- Issued Date
- 06/08/2026
- Storage
- Lyophilised: -20C. Reconstituted: 2-8C, use within 28 days
- Shipping
- USA same-day. Canada, Australia, UK, Europe
- Research Use
- In-vitro laboratory research only
Reconstitution Guide
Reconstitute using sterile bacteriostatic water. Inject slowly down the inner wall of the vial and gently swirl until dissolved. Never shake. Store reconstituted solution at 2-8C and use within 28 days.
Shipping
Same-day USA dispatch before daily cut-off Monday to Friday. International delivery to Canada, Australia, UK and Europe in 5-12 business days.
Related Healing Research Compounds
- BPC-157 20mg — Body Protection Compound Healing Peptide
- TB-500 10mg — Thymosin Beta-4 Healing Peptide
- Wolverine+ Blend 30mg — KPV + BPC-157 + TB-500
- KPV 10mg — Anti-Inflammatory Tripeptide Research
- ARA-290 10mg — Erythropoietin-Derived Peptide
Scientific References
- Sikiric et al. — BPC-157 tissue healing review (PubMed)
- Goldstein et al. — Thymosin Beta-4 wound healing (PubMed)
- ClinicalTrials.gov — BPC-157 & Thymosin Research
Research Use Only. Not FDA-approved for human consumption, veterinary use or clinical application.
Frequently Asked Questions
What is the BPC-157 + TB-500 blend?
This blend combines BPC-157 (a gastric pentadecapeptide) and TB-500 (a Thymosin Beta-4 fragment) in a single pre-combined vial, allowing researchers to study both healing-pathway compounds together.
What purity is the Peptalix Labs BPC-157/TB-500 blend?
Independently tested at 99.79% purity by ILS Laboratories (San Diego, ISO/IEC 17025 accredited) via a full QC panel. Net content: BPC-157 10.70mg + TB-500 10.29mg, Lot 128-01-SM, COA #COA-2026-RNX8QR.
Which lab tested this blend, and is the COA verifiable?
ILS Laboratories, an ISO/IEC 17025 accredited facility in San Diego, CA. The COA can be independently verified at portal.ils-lab.com using Access Code 6LSDDDWA.
Does this blend include heavy metals testing?
Yes. The full QC panel includes heavy metals analysis (arsenic, cadmium, chromium, mercury, lead) — all returned ‘Not Detected’ / Pass, alongside a negative fentanyl screen.
How is the BPC-157/TB-500 blend stored?
Store the sealed lyophilised vial at -20C. Once reconstituted with bacteriostatic water, store at 2-8C and use within 28 days. Do not freeze a reconstituted solution.
How do I reconstitute this blend?
Draw the desired volume of sterile bacteriostatic water into a fresh syringe and inject slowly down the inner wall of the vial. Gently swirl until fully dissolved. Never shake.
Why study BPC-157 and TB-500 together?
BPC-157 is studied for gastric/tissue healing and angiogenesis, while TB-500 is studied for actin regulation and cell migration. Combined research allows comparison of complementary healing mechanisms.
Can I buy this blend online in the USA?
Yes. Peptalix Labs offers the BPC-157 + TB-500 20mg blend for purchase online for qualified USA researchers, with full QC panel COA verification.
Does Peptalix Labs ship this blend internationally?
Yes, to Canada, Australia, the United Kingdom and most of Europe, with tracked delivery in 5-12 business days.
Is this blend the same as buying BPC-157 and TB-500 separately?
The pre-combined blend offers fixed-ratio dosing (BPC-157 10.70mg / TB-500 10.29mg) from a single vial. Researchers wanting independent ratio control may prefer purchasing each compound separately.
Is this blend legal to purchase in the USA?
Yes, as a research chemical for qualified researchers conducting in-vitro laboratory studies. Not FDA-approved for human use. Sold strictly for research purposes.
What does ‘Identity (HPLC-RTM): Confirmed’ mean on the COA?
This confirms that retention-time matching analysis verified both BPC-157 and TB-500/TB-4 are present and correctly identified within the sample, in addition to purity quantification.
What other blends does Peptalix Labs offer for healing research?
Peptalix Labs also offers the triple-compound Wolverine+ blend (KPV + BPC-157 + TB-500 30mg) for researchers studying combined anti-inflammatory and healing pathways.
What is the appearance of this blend?
Lyophilised powder, rated ‘Good’ appearance on the ILS Laboratories COA, consistent with standard peptide blend presentation.
What other healing peptides pair with this blend in research?
Researchers studying this blend often also investigate KPV, ARA-290, and Thymosin Alpha-1 as part of broader anti-inflammatory and tissue-repair research panels.
